Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Health Trends (NHTC) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Natural Health Trends (NHTC) over the last 16 years, with Q3 2025 value amounting to $14.3 million.

  • Natural Health Trends' Cash & Equivalents fell 3749.84% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year decrease of 3749.84%. This contributed to the annual value of $13.5 million for FY2024, which is 7592.72% down from last year.
  • According to the latest figures from Q3 2025, Natural Health Trends' Cash & Equivalents is $14.3 million, which was down 3749.84% from $10.5 million recorded in Q2 2025.
  • Over the past 5 years, Natural Health Trends' Cash & Equivalents peaked at $90.7 million during Q1 2021, and registered a low of $10.5 million during Q2 2025.
  • Its 5-year average for Cash & Equivalents is $53.3 million, with a median of $61.6 million in 2023.
  • In the last 5 years, Natural Health Trends' Cash & Equivalents tumbled by 538.28% in 2021 and then plummeted by 7592.72% in 2024.
  • Natural Health Trends' Cash & Equivalents (Quarter) stood at $84.4 million in 2021, then decreased by 17.33% to $69.7 million in 2022, then dropped by 19.4% to $56.2 million in 2023, then tumbled by 75.93% to $13.5 million in 2024, then increased by 5.93% to $14.3 million in 2025.
  • Its Cash & Equivalents stands at $14.3 million for Q3 2025, versus $10.5 million for Q2 2025 and $21.7 million for Q1 2025.